
Cellular mechanics from the molecular to the tissue scale
Events
21
Mar
2024
2:00 pm
Thesis
Thesis by Nesrine Safia RACHEDI
«"Role of extracellular matrix remodeling in the reprogramming of pulmonary vascular cells during pulmonary arterial hypertension" […]
IPMC
28
Jun
2024
2:00 pm
Thesis
HDR Stephanie TORRINO
«Post-translational modifications at the heart of mechanobiology» Jury President: Christophe LAMAZE
IPMC
12
Jul
2024
Conference
T. BERTERO invites Dr Stephen Y CHAN
«Developing a precision medicine approach to vascular inflammation and pulmonary hypertension»
IPMC
24
Mar
2026
11:00 am
Conference
Thomas BERTERO invites Dr. Gregory LAVIEU
«Genetic Screening Identifies WNT5A/RYK as a Determinant of Extracellular Vesicle Fate»
IPMC
24
Mar
2026
2:00 pm
Thesis
Eirini FYTILI's Thesis
«Characterization of Ubiquitin Domain containing protein 1 (UBTD1) structure and localization in epithelial cells». Thesis director: Stephan Clavel
IPMC
27
Mar
2026
2:00 pm
Thesis
Keren FRAISSART's thesis
«"Microtubules' glutamylation and resistance to treatment in breast cancer." Thesis supervisors: Thomas BERTERO & Stéphanie TORRINO
IPMC
Job offers
Publications
2024
Pulmonary primary oxysterol and bile acid synthesis as a predictor of outcomes in pulmonary arterial hypertension.
bioRxiv 2024 Jan; (): .
2024
GLS2 links glutamine metabolism and atherosclerosis by remodeling artery walls.,
Nat Cardiovasc Res 2024 Nov; (): .
2024
Mechano-dependent sorbitol accumulation supports biomolecular condensate.,
Cell 2024 Nov; (): .
2024
Dietary intake and glutamine-serine metabolism control pathologic vascular stiffness.,
Cell Metab 2024 Jun; 36(6): 1335-1350.e8.
2024
Allele-specific control of rodent and human lncRNA KMT2E-AS1 promotes hypoxic endothelial pathology in pulmonary hypertension.
Sci Transl Med 2024 Jan; 16(729): eadd2029.
2023
Persistent organic pollutants promote aggressiveness in prostate cancer.,
Oncogene 2023 Sep; 42(38): 2854-2867.
2023
Frataxin deficiency disrupts mitochondrial respiration and pulmonary endothelial cell function.
Vascul Pharmacol 2023 Aug; 151(): 107181.
2023
Single Nucleotide Polymorphism rs9277336 Controls the Nuclear Alpha Actinin 4-Human Leukocyte Antigen-DPA1 Axis and Pulmonary Endothelial Pathophenotypes in Pulmonary Arterial Hypertension.
J Am Heart Assoc 2023 Apr; 12(7): e027894.
2022
Metabo-reciprocity in cell mechanics: feeling the demands/feeding the demand.
Trends Cell Biol 2022 Jul; 32(7): 624-636.
2021
Computational repurposing of therapeutic small molecules from cancer to pulmonary hypertension.
Sci Adv 2021 Oct; 7(43): eabh3794.
2021
Brown adipose tissue monocytes support tissue expansion.
Nat Commun 2021 Sep; 12(1): 5255.
2021
Simultaneous Pharmacologic Inhibition of Yes-Associated Protein 1 and Glutaminase 1 via Inhaled Poly(Lactic-co-Glycolic) Acid-Encapsulated Microparticles Improves Pulmonary Hypertension.
J Am Heart Assoc 2021 Jun; 10(12): e019091.
2021
Frataxin deficiency promotes endothelial senescence in pulmonary hypertension.
J Clin Invest 2021 Jun; 131(11): .
2021
Matrix stiffening induces a pathogenic QKI-miR-7-SRSF1 signaling axis in pulmonary arterial endothelial cells.
Am J Physiol Lung Cell Mol Physiol 2021 May; 320(5): L726-L738.
2021
UBTD1 regulates ceramide balance and endolysosomal positioning to coordinate EGFR signaling.
Elife 2021 Apr; 10(): .
2020
Long Range Endocrine Delivery of Circulating miR-210 to Endothelium Promotes Pulmonary Hypertension.
Circ Res 2020 Aug; 127(5): 677-692.
2019
Characterization of Kcnk3-Mutated Rat, a Novel Model of Pulmonary Hypertension.
Circ Res 2019 Sep; 125(7): 678-695.
2019
Inhibition of CHK 1 (Checkpoint Kinase 1) Elicits Therapeutic Effects in Pulmonary Arterial Hypertension.,
Arterioscler Thromb Vasc Biol 2019 Aug; 39(8): 1667-1681.
2019
The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension.,
Expert Opin Ther Targets 2019 Jun; 23(6): 511-524.
2019
BOLA (BolA Family Member 3) Deficiency Controls Endothelial Metabolism and Glycine Homeostasis in Pulmonary Hypertension.
Traffic 2019 May; 139(19): 2238-2255.
2019
UBTD1 is a mechano-regulator controlling cancer aggressiveness.,
EMBO Rep 2019 Apr; 20(4): .
2019
Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.,
Traffic 2019 Feb; 139(7): 932-948.
2019
Tumor-Stroma Mechanics Coordinate Amino Acid Availability to Sustain Tumor Growth and Malignancy.,
Cell Metab 2019 Jan; 29(1): 124-140.e10.
2019
Mechanical forces rewire metabolism in the tumor niche.
Mol Cell Oncol 2019; 6(3): 1592945.
2018
Longitudinal Evaluation of Pulmonary Arterial Hypertension in a Rhesus Macaque (Macaca mulatta) Model of HIV Infection.,
Comp Med 2018 Dec; 68(6): 461-473.
2018
Matrix Stiffening and EGFR Cooperate to Promote the Collective Invasion of Cancer Cells.,
Cancer Res 2018 Sep; 78(18): 5229-5242.
2018
Factors Associated with Heritable Pulmonary Arterial Hypertension Exert Convergent Actions on the miR-130/301-Vascular Matrix Feedback Loop.,
Int J Mol Sci 2018 Aug; 19(8): .
2017
Membrane-bound ICAM-1 contributes to the onset of proinvasive tumor stroma by controlling acto-myosin contractility in carcinoma-associated fibroblasts.
Oncotarget 2017 Jan; 8(1): 1304-1320.
2017
Impact of MicroRNAs in the Cellular Response to Hypoxia.
Int Rev Cell Mol Biol 2017; 333(): 91-158.
2016
p38MAPK builds a hyaluronan cancer niche to drive lung tumorigenesis.,
Genes Dev 2016 Dec; 30(23): 2623-2636.
2016
Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension.,
J Clin Invest 2016 Sep; 126(9): 3313-35.
2015
Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts.,
Nat Commun 2015 Dec; 6(): 10204.
2015
A YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditions.,
Sci Rep 2015 Dec; 5(): 18277.
2015
Matrix Remodeling Promotes Pulmonary Hypertension through Feedback Mechanoactivation of the YAP/TAZ-miR-130/301 Circuit.,
Cell Rep 2015 Nov; 13(5): 1016-32.
2015
The microRNA-130/301 family controls vasoconstriction in pulmonary hypertension.,
J Biol Chem 2015 Jan; 290(4): 2069-85.
2014
MicroRNA target identification: lessons from hypoxamiRs.
Antioxid Redox Signal 2014 Sep; 21(8): 1249-68.
2014
Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension.,
J Clin Invest 2014 Aug; 124(8): 3514-28.
2014
miR-193b/365a cluster controls progression of epidermal squamous cell carcinoma.,
Carcinogenesis 2014 May; 35(5): 1110-20.
2013
Tumor suppressor function of miR-483-3p on squamous cell carcinomas due to its pro-apoptotic properties.
Cell Cycle 2013 Jul; 12(14): 2183-93.
2013
CDC25A targeting by miR-483-3p decreases CCND-CDK4/6 assembly and contributes to cell cycle arrest.
Cell Death Differ 2013 Jun; 20(6): 800-11.
2013
MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines.
Cell Death Dis 2013 Mar; 4(3): e544.
2012
«Seed-Milarity» confers to hsa-miR-210 and hsa-miR-147b similar functional activity.,
PLoS One 2012;7(9):e44919.
2011
miR-483-3p controls proliferation in wounded epithelial cells.,
FASEB J 2011 Sep; 25(9): 3092-105.
2011
miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity.,
Cell Death Differ 2011 Mar; 18(3): 465-78.
2009
Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions.,
PLoS One 2009 Aug; 4(8): e6718.







